GRPR Expression in Metastatic Cancers: A Review of Potential Application of GRPR-Radioligand Therapy
{{output}}
Gastrin-Releasing Peptide Receptor (GRPR) represents a promising molecular target for radionuclide therapy (TRT) across a variety of malignancies due to its overexpression in several tumor types, including prostate, breast, lung, melanoma, cervix, neuroblastom... ...
